14 company-specific changes
fiscal period 2026-07-31
filed 20260910
- Material M&A risk removed. CyberArk acquisition uncertainty, regulatory approval risk, and $1B termination fee exposure eliminated by deal completion or termination.
- New convertible debt obligation (2030 Notes) with material refinancing and liquidity risk. Uncertainty over cash availability for repurchase, conversion, or maturity payments; potential covenant violations and cross-default risk.
See the full detail →
2 company-specific changes
fiscal period 2026-07-31
filed 20260909
- Expansion into consumer lending and new products materially broadens credit risk exposure and customer base concentration, escalating default and fraud risks.
- Escalated AI investment commitment and expanded scope (agentic AI, internal operations). Added risk that benefits may not materialize, signaling heightened financial exposure and execution risk.
See the full detail →
5 company-specific changes
fiscal period 2026-07-25
filed 20260902
- Risk escalated: added memory component shortages as current/ongoing issue, expanded purchase commitment scope (fiscal 2026), increased inventory deposits/prepayments, and heightened AI infrastructure demand unpredictability.
- New material risk: AI infrastructure sales to hyperscalers now explicitly disclosed as concentrated, volatile, and dependent on limited customers' capex timing and AI deployment decisions.
See the full detail →
8 company-specific changes
fiscal period 2026-06-30
filed 20260821
- Added disclosure of reliance on limited suppliers for critical components (specialty electronics, rare earths, aerospace alloys) and supply concentration risk from acquisitions—substantive new operational vulnerability.
- Added divestiture risks and specific completed acquisitions (FGC, Curtis). Expanded scope of strategic transaction risks materially increases disclosed exposure.
See the full detail →
12 company-specific changes
fiscal period 2026-06-27
filed 20260821
- Material M&A transaction newly disclosed with multiple substantive risks: financing uncertainty, regulatory (HSR) approval risk, operational disruption, shareholder dilution, and litigation exposure.
- New material risk: pending transaction with $1.164B termination fee, HSR approval uncertainty, stock price decline risk, and significant operational disruption if deal fails.
See the full detail →
6 company-specific changes
fiscal period 2026-07-03
filed 20260814
- New disclosure of material long-term customer contracts with fixed/formula pricing that limit pricing flexibility, create execution risk, and expose company to opportunity costs and potential revenue loss if unable to perform or if customers breach.
- Revenue concentration worsened: Cloud revenue increased 88% to 89%, top 10 customers increased 68% to 73%. New AI-related demand risk disclosed.
See the full detail →
3 company-specific changes
fiscal period 2026-06-30
filed 20260814
- New disclosure of material Berry acquisition integration risk, including $650M synergy target and failure-to-realize risk affecting financial results.
- New disclosure of active portfolio review targeting $2.5B in sales for divestiture/restructuring. Material strategic uncertainty, execution risk, and potential business disruption that investors would act on.
See the full detail →
13 company-specific changes
fiscal period 2026-06-30
filed 20260813
- New material liability exposure from VirtuOx acquisition. Professional malpractice claims in diagnostic services could exceed insurance coverage, creating uninsured liability risk.
- New direct federal healthcare oversight from acquisitions of IDTF and DME/device businesses subject to Medicare enrollment and FDA regulation. Material regulatory exposure.
See the full detail →
3 company-specific changes
fiscal period 2026-06-27
filed 20260813
- Disclosure of $114.7M probable IEEPA tariff refund receivable and new Section 301/338 tariffs (10-12.5%) materially escalate tariff risk and financial exposure beyond prior generic warnings.
- New disclosure of Ohio-to-Pennsylvania fulfillment center transition with explicit risks: disruptions, increased costs, third-party reliance. Material operational change.
See the full detail →
6 company-specific changes
fiscal period 2026-06-30
filed 20260811
- IRS issued two NOPAs in fiscal 2026 challenging ~$400M self-insurance deduction and ~$160M restructuring transaction, totaling ~$1.6B potential liability plus interest. Concrete, quantified tax exposure materially worsened.
- New disclosure of material MSO acquisition strategy with $184M goodwill impairment, regulatory risks limiting practice ownership, and integration execution risks.
See the full detail →
10 company-specific changes
fiscal period 2026-06-30
filed 20260807
- Debt doubled from $2.5B to $5.1B due to GOJO acquisition and Glad buyout. S&P downgrade to BBB from BBB+ disclosed. Increased leverage risk and covenant pressure substantively worsened.
- Material escalation: Added specific disclosure of major GOJO acquisition (April 2026) and Glad buyout (January 2026), with detailed integration risks, B2B channel conflicts, and significant new debt/liquidity impacts.
See the full detail →
6 company-specific changes
fiscal period 2026-06-28
filed 20260807
- Added specific AI-driven demand risk with concrete scaling and hiring challenges; escalates from generic cyclicality to material competitive/operational pressure.
- New disclosure of Middle East conflict impact on semiconductor supply chain, including oil/commodity disruptions and Strait of Hormuz closure affecting critical inputs.
See the full detail →
1 company-specific change
fiscal period 2026-06-30
filed 20260807
- Ownership structure shifted from Murdoch Family Trust to LGC Holdco with materially different control mechanics. Lachlan Murdoch's direct control over voting via managing director appointment represents escalated concentration risk and governance change.
See the full detail →
8 company-specific changes
fiscal period 2026-06-30
filed 20260806
- New September 2025 Affiliates Rule expands export controls to foreign entities owned by listed parties, increasing compliance burden. Actual shipment delays from U.S. Customs now disclosed. China revenue declined 30% from 33% YoY.
- Added specific rare earth export controls (April, October 2025), China's 70-90% dominance, and new DRAM chip shortage with quantified gross margin impact in fiscal 2027.
See the full detail →
12 company-specific changes
fiscal period 2026-06-30
filed 20260806
- New material M&A risk: $2.136B termination fee exposure, regulatory approval uncertainty, and potential adverse business impact from deal delay or failure.
- New material merger risk: significant transaction costs, operational restrictions, management distraction, litigation exposure, and stock price volatility from pending merger agreement.
See the full detail →
10 company-specific changes
fiscal period 2026-06-30
filed 20260806
- New November 2025 Bike+ recall disclosed; explicit statement that additional recall costs may be material; escalated product safety risk.
- Removal of explicit going-concern risk disclosure regarding chronic operating losses since inception. Signals improved financial position or profitability achievement.
See the full detail →
1 company-specific change
fiscal period 2026-06-30
filed 20260804
- Added explicit disclosure of "buying alliances" and "changing customer practices driven by digital tools and investment in media platforms" as new negotiation pressures, escalating customer concentration risk.
See the full detail →
1 company-specific change
fiscal period 2026-07-03
filed 20260804
- Added specific quantification: one customer represents 14% of revenue. This concrete disclosure of customer concentration escalates the risk from general to measurable, making the impact more tangible to investors.
See the full detail →
5 company-specific changes
fiscal period 2026-06-30
filed 20260804
- New disclosure of digital assets (Canton Coins) as Validator/Super Validator with material impairment and loss risks including fraud, theft, cyberattacks, and regulatory uncertainty.
- New specific regulatory risks disclosed: SEC's Regulation E-Delivery threatens recurring and distribution revenues; tokenized securities regulatory uncertainty requires potential business model changes.
See the full detail →
1 company-specific change
fiscal period 2026-05-31
filed 2026-07-29
- New material risk: proposed $2.8B UniFirst acquisition with regulatory, integration, and financing uncertainties. Adds substantial debt, management distraction, and deal-failure costs.
See the full detail →
30 company-specific changes
fiscal period 2026-05-31
filed 2026-07-29
- New material risk: consolidation of 96%-owned ChronoScale creates financial reporting dependency, audit timing risk, and potential restatement exposure affecting investor confidence and capital access.
- New disclosure of restrictive debt covenants and default risks from May 2026 credit facility. Material covenant breach and acceleration risk could impair liquidity and operations.
See the full detail →
7 company-specific changes
fiscal period 2026-06-30
filed 2026-07-29
- Newly disclosed material risk: substantial capital investments in AI/cloud infrastructure ahead of revenue realization, with explicit concerns about demand forecasting, asset impairment, margin pressure, and strategic partner dependency.
- Substantially expanded disclosure of infrastructure constraints: power availability/costs, permitting delays, regulatory/environmental barriers, community opposition, labor shortages now explicitly detailed as material risks to growth execution.
See the full detail →
5 company-specific changes
fiscal period 2026-04-30
filed 2026-07-29
- New disclosure of $394M financing need for flagship project. Failure to secure capital risks indefinite delay or abandonment, directly threatening company's strategic viability and shareholder value.
- New disclosure of imminent permit expiration (June 2027) with material consequences: loss of ISP would delay/prevent CK Gold Project development, increase costs, jeopardize project financing, and trigger agreement conditions. Substantive operational and financial risk.
See the full detail →
2 company-specific changes
fiscal period 2025-12-31
filed 2026-07-29
- Trust account cash depleted from $9.1M to $641K; redemptions increased from $126M to $135M. Severe liquidity deterioration threatens ability to fund business combination.
- Trust account cash depleted from $9.1M to $641K—a 93% decline. Redemptions increased from 11.9M to 12.6M shares. Liquidity crisis materially worsened.
See the full detail →
10 company-specific changes
fiscal period 2026-04-30
filed 2026-07-29
- Company is currently non-compliant with Nasdaq minimum bid price requirement and faces delisting risk. This materially threatens liquidity, capital-raising ability, and stock trading market access.
- New Nasdaq delisting rule with immediate suspension risk if MVLS falls below $5M for 30 days. Company acknowledges MVLS may already be at or near threshold. Delisting would severely impair liquidity and capital-raising ability.
See the full detail →
9 company-specific changes
fiscal period 2026-05-31
filed 2026-07-28
- Nasdaq delisting risk removed. Company regained compliance with minimum bid price requirement, eliminating material threat to exchange listing and market access.
- New 2025 federal legislation redefining hemp with total-THC standard effective November 2026 may render current products non-compliant. Materially escalates regulatory risk and product viability uncertainty.
See the full detail →
1 company-specific change
fiscal period 2026-04-30
filed 2026-07-27
- Cash balance halved ($9.8M to $4.9M), swung to operating loss ($4.7M income to $1.2M loss), and cash burn accelerated. Liquidity runway materially tightened.
See the full detail →
2 company-specific changes
fiscal period 2026-05-29
filed 2026-07-27
- Customer concentration risk decreased materially. Top-5 customer concentration fell from 77% to 70% in fiscal 2026; top-3 customers now 51% versus prior top-2 at 54%, showing improved diversification.
- Removal of material China trade/tariff risk disclosure signals eased geopolitical tension or reduced China exposure. Reasonable investors would view this as substantive risk mitigation.
See the full detail →
7 company-specific changes
fiscal period 2026-05-31
filed 2026-07-20
- Major spin-off completed June 2026 introduces material risks: failure to realize strategic/financial benefits, counterparty performance obligations, shared IP/brand reputation exposure, and equity divestiture uncertainty.
- New disclosure of material tax risk from spin-off. IRS could challenge tax-free treatment, resulting in substantial tax liability to company and stockholders despite PLR.
See the full detail →
2 company-specific changes
fiscal period 2026-05-31
filed 2026-07-17
- Removal of material M&A integration risk disclosure suggests Paycor integration substantially completed or risks resolved. Material risk eased.
- New disclosure of market expansion strategy and standalone product development risk. Adds material business execution risk beyond technology pace-of-change.
See the full detail →
4 company-specific changes
fiscal period 2026-05-31
filed 2026-07-15
- Competition for endorsers intensified due to athlete personal brands and competing ventures. New risk that key endorsers may launch competing brands, escalating competitive threat.
- Added specific demand drivers: fashion/trend shifts, brand relevance decline, competition, retailer decisions, promotional actions. Escalates inventory risk from generic forecasting to concrete market pressures.
See the full detail →
7 company-specific changes
fiscal period 2026-05-31
filed 2026-07-15
- New EPR laws and FDA dye phase-out requirements disclosed. Specific regulatory mandates requiring packaging changes, reformulation, and increased compliance costs represent material new regulatory risks.
- Removal of a specific, quantified third-party cybersecurity risk that caused $4.4M in charges suggests the risk has been resolved or mitigated materially.
See the full detail →
1 company-specific change
fiscal period 2026-05-31
filed 2026-07-01
- Goodwill and indefinite-lived intangible assets decreased from $22.4B to $20.6B. Impairment risk brands narrowed from five to two, indicating reduced impairment exposure.
See the full detail →
15 company-specific changes
fiscal period 2026-05-31
filed 2026-06-22
- Major CEO succession: Magouyrk and Sicilia elevated to co-CEOs; Catz transitioned from CEO to Executive Vice Chair. Significant leadership restructuring with governance implications.
- Substantially expanded disclosure of material operational and financial risks: customer non-payment/non-performance, power constraints from AI demand, regulatory/permitting delays, long-term power agreements misaligned with customer contracts, and execution risks in data center expansion.
See the full detail →
5 company-specific changes
fiscal period 2026-04-24
filed 2026-06-18
- New disclosure of material separation risk: MiniMed IPO completed, 90% retained, further divestiture planned. Significant execution, cost, tax, and operational risks disclosed.
- Removal of material tax risk. Prior disclosure warned of potential IRS reclassification as U.S. corporation with substantially greater tax liability. Deletion suggests risk resolved or no longer material.
See the full detail →
5 company-specific changes
fiscal period 2026-04-30
filed 2026-06-09
- Sweet Baked Snacks goodwill fully impaired; Hostess trademark reclassified to finite-lived; continued underperformance and impairments signal worsening asset quality.
- Removal of specific Jif peanut butter recall litigation disclosure. Prior year disclosed ongoing consumer litigation with unpredictable outcome; current year omits this material contingency entirely.
See the full detail →
7 company-specific changes
fiscal period 2026-04-24
filed 2026-06-05
- ERP implementation shifted from prospective risk to realized disruption. Company now discloses actual impacts on order processing and invoicing, not just potential risks.
- New disclosure that higher compensation costs may not be offset by innovation or sales; added shareholder approval risk for equity awards; removed sales force productivity language.
See the full detail →
9 company-specific changes
fiscal period 2026-03-31
filed 2026-05-29
- Removal of Section 7874 tax risk eliminates material dual-taxation exposure and withholding tax liability that could have materially harmed financial condition.
- New specific legislative risk disclosed: OBBBA may reduce Medicaid funding and reimbursements, directly threatening customer purchasing power and revenue.
See the full detail →
7 company-specific changes
fiscal period 2026-03-31
filed 2026-05-22
- Added specific $3.5B goodwill impairment charge from fiscal 2025, demonstrating realized acquisition integration failure and material asset write-down.
- Tariff risk escalated from speculative to concrete: Supreme Court ruling, 10% global tariff implementation, and ongoing legal uncertainty now disclosed as actual events affecting business.
See the full detail →
13 company-specific changes
fiscal period 2026-03-31
filed 2026-05-22
- Added material risks: global transportation/logistics disruptions, labor disputes, automation/system integration failures, 3PL transition risks, and broader supply chain inefficiencies.
- Added explicit geographic concentration risk in Vietnam and Indonesia; new disclosure of manufacturer liquidity constraints and financing limitations affecting production capacity.
See the full detail →